Peptide Reference Database
Clinical reference database covering mechanisms, dosing protocols, combinations, and contraindications.
Want a personalised protocol?
Our AI generator builds a protocol tailored to your profile and goals.
3 peptides
Semaglutide
Ozempic Β· Wegovy
Long-acting GLP-1 receptor agonist with FDA approval for T2 diabetes and obesity.
Tirzepatide
Mounjaro Β· Zepbound
Dual GIP/GLP-1 receptor agonist (first in class) with superior weight loss outcomes (~22% body weight) compared to semaglutide in head-to-head trials.
AOD-9604
Anti-Obesity Drug 9604 Β· hGH Fragment 176-191
Fragment of human GH (amino acids 176β191) that retains the lipolytic activity of GH without promoting growth or affecting blood sugar.
MaraPeptide Β· NAD+ revolution
Improve your energy, appearance and recovery the natural way in just a few weeks
Complete NAD+ protocol for free!